Keyphrases
Gross Motor Function Classification System (GMFCS)
100%
Cerebral Palsy children
100%
Botulinum Neurotoxin (BoNT)
100%
Good Responders
100%
Spastic Cerebral Palsy
66%
Poor Responders
66%
Ashworth Scale
66%
Treatment Outcome
33%
Patient Expectations
33%
Favorable Outcome
33%
Response to Treatment
33%
Patient Selection
33%
Parent Questionnaire
33%
Spasticity
33%
Clinical Assessment
33%
Walker
33%
Cerebral Palsy
33%
Score Function
33%
Ambulatory Status
33%
Range of Motion
33%
Lower Limb muscles
33%
Ankle Dorsiflexion
33%
Botulinum Toxin Injection
33%
Knee Extension
33%
Modified Ashworth Scale
33%
Muscle Tone
33%
Pre-injection
33%
Medicine and Dentistry
Spastic Diplegia
100%
Gross Motor Function Measure
100%
Clostridium Botulinum Type A
100%
Botulinum Toxin A
66%
Clinical Assessment
33%
Range of Motion
33%
Hemiplegia
33%
Spasticity
33%
Muscle Tone
33%
Patient Selection
33%
Biochemistry, Genetics and Molecular Biology
Motor Performance
100%
Clostridium Botulinum Type A
100%
Botulinum Toxin A
66%
Range of Motion
33%
Muscle Tone
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebral Palsy
100%
Clostridium Botulinum Type A
100%
Botulinum Toxin A
66%
Hemiplegia
33%
Spasticity
33%
Neuroscience
Cerebral Palsy
100%
Clostridium Botulinum Type A
100%
Botulinum Toxin A
66%
Clinical Assessment
33%